SCHEMBL3378780

SCHEMBL3378780

CC1Cc2cccc(O)c2C1=O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 4/20 0.62
MAOB P27338 2/20 0.62
ACHE P22303 8/20 0.53
MEN1 O00255 1/20 0.50
USP2 O75604 1/20 0.50
ALDH1A1 P00352 1/20 0.50
HPN P05981 1/20 0.50
CYP3A4 P08684 1/20 0.50
ALOX5 P09917 1/20 0.50
MAPT P10636 1/20 0.50
THRB P10828 1/20 0.50
ALOX15 P16050 1/20 0.50
TSHR P16473 1/20 0.50
PTGS1 P23219 1/20 0.50
PDE4A P27815 1/20 0.50
KDR P35968 1/20 0.50
KMT2A Q03164 1/20 0.50
HSD17B10 Q99714 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
SIRT5 Q9NXA8 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5952103 0.84 ACHE (0.59) MAOAMAOBACHEMEN1USP2
SCHEMBL7185650 0.81 ACHE (0.53) MAOAMAOBACHEHTR1ADRD2
SCHEMBL27949953 0.79 MAOA (0.51) MAOAMAOBMEN1USP2ALDH1A1
SCHEMBL28303987 0.79 MAOA (0.51) MAOAMAOBACHEMEN1USP2
SCHEMBL5951341 0.79 ACHE (0.52) MAOAMAOBACHEABCB1HTR2A
SCHEMBL5951770 0.79 ACHE (0.52) MAOAMAOBACHESTAT3DRD2
SCHEMBL5951495 0.79 ACHE (0.52) MAOAMAOBACHESTAT3ABCB1
SCHEMBL5951497 0.79 ACHE (0.51) MAOAMAOBACHEMEN1KMT2A
SCHEMBL5952912 0.77 ACHE (0.50) MAOAMAOBACHESTAT3HTR1A
SCHEMBL5952340 0.77 ACHE (0.50) MAOAMAOBACHEALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1401880-B1 METALLOCENE CATALYSTS CONTAINING AN INDENYL MOIETY SUBSTITUTED AT THE 4-, 5-, 6- OR 7-POSITION BY A SILOXY OR GERMYLOXY GROUP BOREALIS TECH OY (FI) 2010-11-10 EP disclosed
US-7074863-B2 Metallocene catalysts containing an idenyl moiety substituted at the 4,-5,-6- or 7-position by a siloxy or germyloxy group BOREALIS TECHNOLOGY OY (FI) 2006-07-11 US disclosed
US-7038070-B2 Preparation of preparing substituted indanones BASELL POLYOLEFINE GMBH (DE) 2006-05-02 US disclosed
US-6963017-B2 Preparation of preparing substituted indanones BASELL POLYOLEFINE GMBH (DE) 2005-11-08 US disclosed
EP-0968158-B1 METHOD OF PREPARING SUBSTITUTED INDANONES, THE SUBSTITUTED INDANONES AND METALLOCENES PREPARED THEREFROM BASELL POLYOLEFINE GMBH (DE) 2005-08-10 EP disclosed
US-20050033076-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2005-02-10 US disclosed
US-20040152882-A1 Metallocene catalysts containing an idenyl moiety substituted at the 4,-5,-6- or 7-position by a siloxy or germyloxy group BOREALIS TECHNOLOGY OY (FI) 2004-08-05 US disclosed
EP-1401880-A1 METALLOCENE CATALYSTS CONTAINING AN INDENYL MOIETY SUBSTITUTED AT THE 4-, 5-, 6- OR 7-POSITION BY A SILOXY OR GERMYLOXY GROUP Borealis Technology Oy (FI) 2004-03-31 EP disclosed
US-20030009046-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2003-01-09 US disclosed
WO-2003000744-A1 METALLOCENE CATALYSTS CONTAINING AN IDENYL MOIETY SUBSTITUTED AT THE 4-, 5-, 6- OR 7-POSITION BY A SILOXY OR GERMYLOXY GROUP BOREALIS TECHNOLOGY OY (FI) 2003-01-03 WO disclosed
EP-0968158-A1 METHOD OF PREPARING SUBSTITUTED INDANONES, THE SUBSTITUTED INDANONES AND METALLOCENES PREPARED THEREFROM Basell Polyolefine GmbH (DE) 2000-01-05 EP disclosed
WO-1998040331-A1 PREPARATION OF PREPARING SUBSTITUTED INDANONES TARGOR GMBH (DE) 1998-09-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050033076-A1 Preparation of preparing substituted indanones CYP1A2, CYP2J2, IDH3A MAOA 498/4885MAOB 334/4885ACHE 839/4885
US-20040152882-A1 Metallocene catalysts containing an idenyl moiety substituted at the 4,-5,-6- or 7-position by a siloxy or germyloxy group IPO4, GEMIN4, GEMIN5 MAOA 3667/4885MAOB 4198/4885ACHE 3443/4885
US-20030009046-A1 Preparation of preparing substituted indanones CYP1A2, CYP1B1, CYP1A1 MAOA 564/4885MAOB 403/4885ACHE 820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.